Skip to content

CORCEPT THERAPEUTICS INC

CORT

CIK 0001088856 · Pharmaceutical Preparations · Nasdaq

← back to feed
Revenue (TTM)
$724.19M
+12.8% YoY Q1 Apr 2026
Net Income (TTM)
$43.6M
−29.4% YoY Q1 Apr 2026
EPS Diluted (TTM)
$0.32
−33.3% YoY Q1 Apr 2026
Gross Margin
11.7%
Q1 Apr 2026
Operating Margin
-1.3%
Q1 Apr 2026
Net Margin
6.0%
Q1 Apr 2026
Free Cash Flow (TTM)
$37.41M
Q1 Apr 2026
Cash
$108.74M
Q1 Apr 2026
Total Debt
$0
Q1 Apr 2026
Shares Outstanding
107.35M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings